Marijuana stocks have rallied in the past few weeks thanks mainly to rising possibility of a Biden victory in the presidential election. A Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
Medical use of marijuana is now legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC. Some more states are expected to legalize marijuana’s recreational use soon.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies.
A “Blue Sweep” could therefore be a game changer for the cannabis industry, which is growing rapidly. We could see a boom in domestic production. In fact, most Americans support marijuana legalization, but the industry is evolving rapidly and therefore these stocks are very volatile.
2019 was a terrible year for most pot stocks and the underperformance continued earlier this year. ETFs lower the risk of investing in this high-risk, high-reward industry.
The ETFMG Alternative Harvest ETF (MJ - Free Report) is the first and largest US listed ETF to target the global cannabis industry. Canopy Growth (CGC - Free Report) , Cronos (CRON - Free Report) and Aurora Cannabis (ACB - Free Report) are its top holdings. The Cannabis ETF (THCX) and the Global X Cannabis ETF (POTX) are also passively managed.
The AdvisorShares Pure Cannabis ETF (YOLO - Free Report) , the Cambria Cannabis ETF (TOKE - Free Report) and the Amplify Seymour Cannabis ETF (CNBS - Free Report) are actively managed. TOKE is the cheapest pot ETF. The newest product in the space-- AdvisorShares Pure US Cannabis ETF (MSOS - Free Report) --is an actively managed ETF that focuses exclusively on US cannabis stocks and swap contracts.
To learn more about these ETFs and their performance, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Marijuana stocks have rallied in the past few weeks thanks mainly to rising possibility of a Biden victory in the presidential election. A Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
Medical use of marijuana is now legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC. Some more states are expected to legalize marijuana’s recreational use soon.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies.
A “Blue Sweep” could therefore be a game changer for the cannabis industry, which is growing rapidly. We could see a boom in domestic production. In fact, most Americans support marijuana legalization, but the industry is evolving rapidly and therefore these stocks are very volatile.
2019 was a terrible year for most pot stocks and the underperformance continued earlier this year. ETFs lower the risk of investing in this high-risk, high-reward industry.
The ETFMG Alternative Harvest ETF (MJ - Free Report) is the first and largest US listed ETF to target the global cannabis industry. Canopy Growth (CGC - Free Report) , Cronos (CRON - Free Report) and Aurora Cannabis (ACB - Free Report) are its top holdings. The Cannabis ETF (THCX) and the Global X Cannabis ETF (POTX) are also passively managed.
The AdvisorShares Pure Cannabis ETF (YOLO - Free Report) , the Cambria Cannabis ETF (TOKE - Free Report) and the Amplify Seymour Cannabis ETF (CNBS - Free Report) are actively managed. TOKE is the cheapest pot ETF. The newest product in the space-- AdvisorShares Pure US Cannabis ETF (MSOS - Free Report) --is an actively managed ETF that focuses exclusively on US cannabis stocks and swap contracts.
To learn more about these ETFs and their performance, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MJ - FREE
Get the latest research report on CRON - FREE
Get the latest research report on CGC - FREE
Get the latest research report on ACB - FREE
Get the latest research report on YOLO - FREE
Get the latest research report on TOKE - FREE
Get the latest research report on CNBS - FREE
Get the latest research report on MSOS - FREE